{{Rsnum
|rsid=3736830
|Gene=KPNA3
|Chromosome=13
|position=49732085
|Orientation=plus
|GMAF=0.3586
|Gene_s=KPNA3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 65.1 | 34.9 | 0.0
| HCB | 9.1 | 54.5 | 36.4
| JPT | 13.6 | 52.3 | 34.1
| YRI | 25.4 | 55.6 | 19.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 9.1 | 54.5 | 36.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22267201
|Trait=None
|Title=Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways.
|RiskAllele=G
|Pval=9E-8
|OR=0.1800
|ORtxt=None
|OA=1
}}{{PMID|15882913}} The KPNA3 gene may be a susceptibility candidate for schizophrenia.

{{PMID|16644122}} A combined effect of the KPNA3 and KPNB3 genes on susceptibility to schizophrenia.